https://www.facebook.com/447215385147042/

Imicron FMN, Zmaj Jovina 30, Kragujevac (2025)

24/10/2025

At the 50th October Health Days, our center’s researcher Prof. Milena Jurišević gave a lecture titled “Repurposing of Antimetabolic Drugs in Breast Cancer.” The session was chaired by Prof. Dr. Ivan Jovanović. Congratulations to Milena on an outstanding presentation!

Na 50. Oktobarskim zdravstvenim danima, istraživač našeg centra prof. Milena Jurišević održala je predavanje „Repurposing of antimetabolic drugs in breast cancer“. Sesijom je predsedavao prof. dr Ivan Jovanović. Čestitamo Mileni na izuzetnom predavanju!

16/10/2025

Congratulations to Dr. Jovana Marinković on being the first author of the recently published paper:
"Silver(I) Complexes Bearing S-Alkyl Thiosalicylic Acid Derivatives: DNA/BSA Binding and Antitumor Activity In Vitro and In Vivo." This work marks an important contribution to the study of silver-based compounds with antitumor potential. This study represents an excellent piece of collaborative work and a valuable contribution to the field of medicinal inorganic chemistry. Wishing her continued success in her scientific career!

Čestitamo dr Jovani Marinković, prvom autoru rada:
"Silver(I) Complexes Bearing S-Alkyl Thiosalicylic Acid Derivatives: DNA/BSA Binding and Antitumor Activity In Vitro and In Vivo". Ovaj rad predstavlja značajan doprinos istraživanju antitumorskih svojstava kompleksa srebra. Ova studija predstavlja odličan primer zajedničkog rada i dragocen doprinos oblasti medicinske neorganske hemije. Želimo joj puno uspeha u daljem naučnom radu!

10/10/2025

Istraživači našeg centra, doc. dr Nevena Gajović i prof. dr Иван Јовановић držali su zapažena predavanja po pozivu na prvom SDIR HDIR MOKAD regionalnom kongresu istraživaca raka u Beogradu. Istovremeno su postavljeni temelji buduće naučne saradnje sa referentnim institucijama iz Budimpešte (Madjarska) Monpeljea (Francuska) i Atine (Grčka).

Researchers from our center, Assoc. Prof. Dr. Nevena Gajović and Prof. Dr. Ivan Jovanović, delivered notable invited lectures at the first SDIR HDIR MOKAD Regional Cancer Research Congress held in Belgrade .info At the same time, the foundations were laid for future scientific collaboration with leading institutions from Budapest (Hungary), Montpellier (France), and Athens (Greece).

09/10/2025

Sa velikim zadovoljstvom delimo vest da je Irfan Corovic član našeg centra, dobitnik National Scholar Award nagrade na UEG Week 2025, najvećem evropskom kongresu gastroenterologije. Njegovo istraživanje pod nazivom “IL-33/ST2-mediated inflammasome activation exacerbates alcohol-induced gastric mucosal damage” proglašeno je najboljim radom iz naše zemlje ove godine, što potvrđuje izuzetnost i značaj našeg kontinuiranog naučnog rada. Pored ove prestižne nagrade, Irfan je osvojio i Travel Grant za svoj izuzetan doprinos. Iskrene čestitke i njegovoj mentorki, dr Bojani Simović Marković, višem naučnom saradniku, čija je podrška i stručnost imala ključnu ulogu u ovom uspehu. Ovo je druga godina zaredom da naš centar dobija ovu prestižnu nagradu na UEG Week, što još jednom potvrđuje našu posvećenost unapređenju gastroenteroloških istraživanja i razvoju nove generacije naučnika.

We are thrilled to share that Irfan Ćorović, a member of our center, has received the National Scholar Award at UEG Week 2025, Europe’s leading congress in gastroenterology. His research, “IL-33/ST2-mediated inflammasome activation exacerbates alcohol-induced gastric mucosal damage,” was recognized as the best study from our country this year, highlighting the excellence and impact of our ongoing scientific work. In addition to this recognition, Irfan was also awarded a Travel Grant for his outstanding contribution. Heartfelt congratulations to his mentor, Dr. Bojana Simović Marković, Senior Research Associate, whose guidance played an essential role in this achievement. This is the second year in a row that our center has received this prestigious award at UEG Week, reaffirming our shared commitment to advancing gastroenterological research and nurturing the next generation of scientists.

06/10/2025

The Nobel Prize for 2025 in Physiology or Medicine goes to Mary E. Brunkow, Fred Ramsdell and Shimon Sakaguchi “for their discoveries concerning peripheral immune tolerance,” the Royal Swedish Academy of Sciences announced in Stockholm on Monday (October 6, 2025).

Nobelova nagrada za fiziologiju ili medicinu za 2025. godinu dodeljena je Mary E. Brunkow, Fredu Ramsdellu i Shimoni Sakaguchiju „Za njihova otkrića u oblasti periferne imunske tolerancije“, saopštila je Kraljevska švedska akademija nauka u ponedeljak, 6. oktobra 2025. godine, u Stokholmu.

04/10/2025

The new study titled "Co-Targeting PD-1 and IL-33/ST2 Pathways for Enhanced Acquired Anti-Tumor Immunity in Breast Cancer" focuses on investigating the role of the IL-33 and PD-1 pathways in strengthening the acquired anti-tumor immune response in patients with breast cancer. The research provides new insights into immune mechanisms that may improve therapeutic outcomes and highlights the potential clinical benefits of simultaneously targeting these signaling pathways. Congratulations to Dr. Marina Jovanović, the first author of the paper, for her outstanding contribution to this important study, which opens new possibilities in breast cancer immunotherapy.

Nova studija pod nazivom ,,Co-Targeting PD-1 and IL-33/ST2 Pathways for Enhanced Acquired Anti-Tumor Immunity in Breast Cancer" fokusira se na istraživanje uloge IL-33 i PD-1 puteva u jačanju stečene antitumorskog imunskog odgovora kod pacijenata sa karcinomom dojke. Istraživanje pruža nove uvide u imunske mehanizme koji mogu poboljšati terapijski odgovor i ukazuje na potencijalnu kliničku korist istovremenog ciljanja ovih signalnih puteva. Čestitamo dr Marini Jovanović, prvoj autorki rada, na izuzetnom doprinosu ovom značajnom istraživanju koje otvara nove mogućnosti u imunoterapiji karcinoma dojke.

02/10/2025

We continue with the congratulations! 👏
We extend our sincere congratulations to Prof. Dr. Ivan Jovanović, Head of our Department, for being included — for the third consecutive time — on the prestigious Stanford list of the top 2% most influential scientists in the world!
This remarkable achievement is a result of his expertise and scientific dedication, but also a reflection of the strength of our research team, the Center for Molecular Medicine and Stem Cell Research, and the valuable collaborations we foster with colleagues from various biomedical fields.
We are proud that such recognition has once again reached our academic community! Professor, congratulations — and thank you for inspiring and leading by example!

Nastavljamo sa čestitkama! 👏
Prof. dr Ivanu Jovanoviću, šefu naše katedre, upućujemo iskrene čestitke povodom toga što je po treći put zaredom uvršten na prestižnu Stanford listu 2% najuticajnijih naučnika sveta!
Ovaj izuzetan uspeh je rezultat njegove stručnosti i naučne posvećenosti, ali i odraz snage istraživačkog tima, Centra za molekulsku medicinu i istraživanje matičnih ćelija, i vrednih saradnji koje negujemo sa kolegama iz drugih biomedicinskih oblasti.
Ponosni smo što je ovakvo priznanje još jednom stiglo kod nas!
Profesore, čestitamo i hvala što svojim primerom inspirišete i vodite!

23/09/2025

We proudly congratulate Prof. Dr. Ivan Jovanović for being recognized for the third consecutive year on the prestigious Stanford list of the world’s top 2% most influential scientists. His dedication and expertise continue to inspire us all. Thank you, Professor, for raising the bar and setting new standards.

Čestitamo Prof. dr Ivanu Jovanoviću koji se treću godinu zaredom našao na prestižnoj Stanford listi 2% najuticajnijih naučnika sveta! Njegova posvećenost i stručnost inspirišu sve nas. Profesore, hvala što pomerate granice i postavljate nove standarde!

17/09/2025

Dr. Kemal Ćorović has successfully defended his PhD thesis “Synthesis, characterization, and evaluation of the biological activity of palladium(II) complexes with dialkyl esters of (S,S)-propylenediamine-N,N′-di-(2,2′-di-(4-hydroxybenzyl))acetic acid.”
The work, conducted at the Center for Molecular Medicine and Stem Cell Research, integrated inorganic chemistry, medicinal chemistry, and tumor biology to design new potential metal-based anticancer complexes. Supervisors were Research Associate Danijela Stojković (University of Kragujevac, Institute for Information Technologies) and Professor Bojan Stojanović (Faculty of Medical Sciences, University of Kragujevac).
Key findings were published in Dalton Transactions (RSC): https://pubs.rsc.org/en/content/articlelanding/2024/dt/d4dt00659c
Congratulations to Dr. Ćorović on this remarkable achievement!

Dr Kemal Ćorović je uspešno odbranio doktorsku disertaciju „Sinteza, karakterizacija i ispitivanje biološke aktivnosti kompleksa paladijuma(II) sa dialkil estrima (S,S)-propilendiamin-N,N’-di-(2,2’-di-(4-hidroksi-benzil)) sirćetne kiseline.”
Istraživanje je sprovedeno u Centru za molekulsku medicinu i istraživanje matičnih ćelija, kombinujući neorgansku i medicinsku hemiju sa biologijom tumora u cilju razvoja novih potencijalnih antitumorskih kompleksa metala. Mentori su bili naučni saradnik Danijela Stojković i prof. Bojan Stojanović (Univerzitet u Kragujevcu).
Rezultati su objavljeni u časopisu Dalton Transactions (RSC): https://pubs.rsc.org/en/content/articlelanding/2024/dt/d4dt00659c
Čestitamo dr Ćoroviću na značajnom uspehu!

11/09/2025

A new study investigates the role of IL-33 as a potential biomarker of poor early response in patients with neuroendocrine tumors undergoing peptide receptor radionuclide therapy. The research highlights the significance of IL-33 in assessing treatment outcomes and contributes to a better understanding of immunological factors involved in the management of these patients. Congratulations to Dr. Katarina Vuleta Nedić, the first author of the paper, for her outstanding contribution to this important study.

Novo istraživanje ispituje ulogu IL-33 kao mogućeg biomarkera slabog ranog odgovora kod pacijenata sa neuroendokrinim tumorima koji se leče peptidno-receptorskom radionuklidnom terapijom. Studija ističe značaj IL-33 u proceni terapijskog ishoda i doprinosi boljem razumevanju imunskih faktora u lečenju ovih pacijenata. Čestitamo dr Katarini Vuleti Nedić, prvoj autorki rada, na izuzetnom doprinosu ovom važnom istraživanju.

05/09/2025

Members of our center are authors of a new scientific paper titled "In Vivo, In Vitro, and In Silico Assessment of Anticancer Activity of the New Pincer-Type Pt(II) Complexes", published in the prestigious Journal of Medicinal Chemistry, a top-tier international journal classified in the highest-ranking M21a+ category. We are proud of the entire research team for their outstanding contribution to the field of medicinal chemistry.
Special congratulations go to Dr. Danijela Nićiforović, the first author of the paper. We also highlight the expertise and dedication of Prof. Snežana Jovanović Stević and senior research associate Dr. Bojana Simović Marković, whose efforts were instrumental in the successful completion of this research.

Članovi našeg centra autori su novog naučnog rada pod nazivom "In Vivo, In Vitro, and In Silico Assessment of Anticancer Activity of the New Pincer-Type Pt(II) Complexes", koji je objavljen u prestižnom časopisu Journal of Medicinal Chemistry, koji pripada M21a+ kategoriji najvišerangiranih međunarodnih naučnih časopisa! Ponosni smo na ceo istraživački tim koji stoji iza ovog značajnog doprinosa u oblasti medicinske hemije.
Posebne čestitke upućujemo dr Danijeli Nićiforović, prvom autoru rada. Takođe, posebno ističemo stručnost i posvećenost Prof. Snežane Jovanović Stević i višeg naučnog saradnika dr Bojane Simović Marković u realizaciji ovog istraživanja.
+

29/08/2025

Our latest study explores the interactions between DNA and BSA (bovine serum albumin), as well as the immunomodulatory effects of a dinuclear platinum(II) complex with an aromatic 1,5-naphthyridine bridging ligand. 🧬⚗️
This research reveals potential pathways for the development of new antitumor agents and contributes to a better understanding of mechanisms at the molecular level.
Congratulations to Jovana Marinković as the first author on this achievement! 👏

Naš najnoviji rad bavi se interakcijama između DNK i BSA (serumskog albumina), kao i imunomodulatornim efektima dinuklearnog platinum(II) kompleksa sa aromatičnim 1,5-naftiridinskim mostom. 🧬⚗️
Ova studija otkriva potencijalne puteve za razvoj novih antitumorskih agenasa i doprinosi boljem razumevanju mehanizama na molekularnom nivou.
Čestitamo Jovani Marinković kao prvom autoru na ovom uspehu! 👏

Imicron FMN

24/10/2025

16/10/2025

10/10/2025

09/10/2025

06/10/2025

04/10/2025

02/10/2025

23/09/2025

17/09/2025

11/09/2025

05/09/2025

29/08/2025

Address

Website

Alerts

Shortcuts

Share

Category